Literature DB >> 23634260

The CDK Network: Linking Cycles of Cell Division and Gene Expression.

Robert P Fisher1.   

Abstract

Cyclin-dependent kinases (CDKs) play essential roles in cell proliferation and gene expression. Although distinct sets of CDKs work in cell division and transcription by RNA polymerase II (Pol II), they share a CDK-activating kinase (CAK), which is itself a CDK-Cdk7-in metazoans. Thus a unitary CDK network controls and may coordinate cycles of cell division and gene expression. Recent work reveals decisive roles for Cdk7 in both pathways. The CAK function of Cdk7 helps determine timing of activation and cyclin-binding preferences of different CDKs during the cell cycle. In the transcription cycle, Cdk7 is both an effector kinase, which phosphorylates Pol II and other proteins and helps establish promoter-proximal pausing; and a CAK for Cdk9 (P-TEFb), which releases Pol II from the pause. By governing the transition from initiation to elongation, Cdk7, Cdk9 and their substrates influence expression of genes important for developmental and cell-cycle decisions, and ensure co-transcriptional maturation of Pol II transcripts. Cdk7 engaged in transcription also appears to be regulated by phosphorylation within its own activation (T) loop. Here I review recent studies of CDK regulation in cell division and gene expression, and propose a model whereby mitogenic signals trigger a cascade of CDK T-loop phosphorylation that drives cells past the restriction (R) point, when continued cell-cycle progression becomes growth factor-independent. Because R-point control is frequently deregulated in cancer, the CAK-CDK pathway is an attractive target for chemical inhibition aimed at impeding the inappropriate commitment to cell division.

Entities:  

Keywords:  CDK-activating kinase (CAK); RNA polymerase II; cell division cycle; cyclin-dependent kinase (CDK); phosphorylation; transcription

Year:  2012        PMID: 23634260      PMCID: PMC3636752          DOI: 10.1177/1947601912473308

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  117 in total

1.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.

Authors:  Stéphane Larochelle; Karl A Merrick; Marie-Emilie Terret; Lara Wohlbold; Nora M Barboza; Chao Zhang; Kevan M Shokat; Prasad V Jallepalli; Robert P Fisher
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

2.  Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics.

Authors:  Stéphane Larochelle; Jasmin Batliner; Matthew J Gamble; Nora M Barboza; Brian C Kraybill; Justin D Blethrow; Kevan M Shokat; Robert P Fisher
Journal:  Nat Struct Mol Biol       Date:  2005-12-04       Impact factor: 15.369

3.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

4.  Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks.

Authors:  Daniel A Gilchrist; George Fromm; Gilberto dos Santos; Linh N Pham; Ivy E McDaniel; Adam Burkholder; David C Fargo; Karen Adelman
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

Review 5.  Progression through the RNA polymerase II CTD cycle.

Authors:  Stephen Buratowski
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

6.  Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.

Authors:  Laurence Bockstaele; Xavier Bisteau; Sabine Paternot; Pierre P Roger
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

7.  Positive feedback of G1 cyclins ensures coherent cell cycle entry.

Authors:  Jan M Skotheim; Stefano Di Talia; Eric D Siggia; Frederick R Cross
Journal:  Nature       Date:  2008-07-17       Impact factor: 49.962

8.  Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK.

Authors:  W J Feaver; J Q Svejstrup; N L Henry; R D Kornberg
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

9.  p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.

Authors:  Arpita Ray; Melissa K James; Stéphane Larochelle; Robert P Fisher; Stacy W Blain
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 5.069

10.  Chemical genetics reveals a specific requirement for Cdk2 activity in the DNA damage response and identifies Nbs1 as a Cdk2 substrate in human cells.

Authors:  Lara Wohlbold; Karl A Merrick; Saurav De; Ramon Amat; Jun Hyun Kim; Stéphane Larochelle; Jasmina J Allen; Chao Zhang; Kevan M Shokat; John H J Petrini; Robert P Fisher
Journal:  PLoS Genet       Date:  2012-08-23       Impact factor: 5.917

View more
  42 in total

1.  High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.

Authors:  Philip Eliades; Brian J Abraham; Zhenyu Ji; David M Miller; Camilla L Christensen; Nicholas Kwiatkowski; Raj Kumar; Ching Ni Njauw; Michael Taylor; Benchun Miao; Tinghu Zhang; Kwok-Kin Wong; Nathanael S Gray; Richard A Young; Hensin Tsao
Journal:  J Invest Dermatol       Date:  2018-02-08       Impact factor: 8.551

2.  Transcriptional CDKs in the spotlight.

Authors:  Joaquin M Espinosa
Journal:  Transcription       Date:  2019-04

3.  Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment.

Authors:  Weiwei Shan; Jiao Yuan; Zhongyi Hu; Junjie Jiang; Yueying Wang; Nicki Loo; Lingling Fan; Zhaoqing Tang; Tianli Zhang; Mu Xu; Yutian Pan; Jiaqi Lu; Meixiao Long; Janos L Tanyi; Kathleen T Montone; Yi Fan; Xiaowen Hu; Youyou Zhang; Lin Zhang
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 4.  Transcription elongation control by the 7SK snRNP complex: Releasing the pause.

Authors:  Ryan P McNamara; Curtis W Bacon; Iván D'Orso
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

5.  Cell Cycle-Dependent Regulation and Function of ARGONAUTE1 in Plants.

Authors:  Adrien Trolet; Patricia Baldrich; Marie-Claire Criqui; Marieke Dubois; Marion Clavel; Blake C Meyers; Pascal Genschik
Journal:  Plant Cell       Date:  2019-06-12       Impact factor: 11.277

Review 6.  Cyclin-dependent kinases as therapeutic targets for HIV-1 infection.

Authors:  Andrew P Rice
Journal:  Expert Opin Ther Targets       Date:  2016-11-10       Impact factor: 6.902

7.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

8.  Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.

Authors:  Uri Mbonye; Benlian Wang; Giridharan Gokulrangan; Wuxian Shi; Sichun Yang; Jonathan Karn
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

9.  THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing.

Authors:  Kyle A Nilson; Jiannan Guo; Michael E Turek; John E Brogie; Elizabeth Delaney; Donal S Luse; David H Price
Journal:  Mol Cell       Date:  2015-08-06       Impact factor: 17.970

10.  Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55α holoenzyme.

Authors:  Alison Kurimchak; Dale S Haines; Judit Garriga; Shufang Wu; Francesco De Luca; Michael J Sweredoski; Raymond J Deshaies; Sonja Hess; Xavier Graña
Journal:  Mol Cell Biol       Date:  2013-06-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.